European Biotech Acquisition Corp.
EBACNASDAQFinancial Services
$11.19
$-0.52(-4.44%)
Market Cap$183500312
P/E Ratio—
52W High$14.1
52W Low$9.282
European Biotech Acquisition Corp.（EBAC）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EBAC · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 |
|---|---|---|
| Revenue | ||
| Revenue | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — |
| Operating Expenses | ||
| R&D Expenses | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — |
| Interest Income | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B |
| Income Before Tax | $0.00B | $0.00B |
| Income Tax Expense | ($0.00B) | $0.00B |
| Net Income | $0.00B | $0.00B |
| Net Margin %(computed) | — | — |
| Per Share & EBITDA | ||
| EPS (Basic) | $0.27 | $0.43 |
| Wtd Avg Shares | 0.01B | 0.00B |
| EBITDA | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解European Biotech Acquisition Corp.
关于European Biotech Acquisition Corp.（EBAC）损益表
European Biotech Acquisition Corp.（EBAC）损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年，EBAC实现营收$0.00B，毛利润$0.00B（毛利率—），净利润$0.00B（净利率—）。
常见问题
EBAC · 4 问European Biotech Acquisition Corp.（EBAC）2022财年营收为$0.00B，同比down—%。
EBAC revenueEBAC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09